LEADER 01750nam  2200373   450 
001 9910688269903321
005 20230630070718.0
024 7 $a10.5772/intechopen.87415
035   $a(CKB)5400000000046104
035   $a(NjHacI)995400000000046104
035   $a(EXLCZ)995400000000046104
100   $a20230630d2021      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aEpstein-Barr Virus $eNew Trends /$fEmmanuel Drout
210  1$aLondon :$cIntechOpen,$d2021.
215   $a1 online resource (130 pages) $cillustrations
225 0 $aInfectious diseases
311   $a1-83968-491-7 
330   $aEpstein-Barr virus (EBV) is a fascinating microorganism, as a "double-facetted" viral agent. After primary infection, it can persist throughout a person's lifetime in a latent form, from which it can reactivate following specific stimuli (i.e., immunodepression). Unlike other herpesviruses, EBV reactivates a countless number of times with such a high replication rate that it is unable to be controlled by conventional anti-herpesvirus drugs. Moreover, for various reasons, no vaccine is currently available in the market. This book presents a comprehensive overview of EBV, including information on its potential for oncogenic activity, its various isolates, and possible vaccine candidates.
517   $aEpstein-Barr Virus 
606   $aEpstein-Barr virus diseases
615  0$aEpstein-Barr virus diseases.
676   $a616.0194
700   $aDrout$b Emmanuel$01368973
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910688269903321
996   $aEpstein-Barr Virus$93395027
997   $aUNINA